Nestomin 0.5 Injection containing Neostigmine is used for the management of neuromuscular disorders and reversal of neuromuscular blockade after surgery. It helps in restoring muscle activity and improving neuromuscular communication.
Neostigmine works by inhibiting acetylcholinesterase, which increases acetylcholine levels at neuromuscular junctions and enhances muscle contraction effectively.
The injection is widely used in hospitals, surgical units, and critical care settings, leading to consistent demand in institutional healthcare segments.
With increasing surgical procedures and growing demand for operative care medicines, this product offers strong business potential for distributors and institutional suppliers. Its essential hospital usage, steady clinical demand, and specialized neuro application make it a reliable product for consistent sales and growth in the critical care segment.
Some patients may experience abdominal cramps, nausea, excessive salivation, sweating, slow heart rate, or muscle twitching. Rarely, severe cholinergic reactions, breathing difficulty, or allergic responses may occur and require immediate medical attention.
Nestomin 0.5 Injection is indicated for the treatment of myasthenia gravis, postoperative urinary retention, paralytic ileus, and reversal of non-depolarizing neuromuscular blockade after surgery. It helps restore muscle activity, improve muscle strength, and support postoperative recovery.
This injection should be administered under strict medical supervision with proper monitoring of cardiac and respiratory function. Use cautiously in patients with asthma, epilepsy, heart disease, or gastrointestinal obstruction. Atropine may be required to counter excessive cholinergic effects if needed.
Store in a cool, dry place below 25°C, protected from light. Do not freeze. Keep out of reach of children.